The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement Agreement reached with Beyond Air

26 May 2021 07:00

RNS Number : 8038Z
Circassia Group Plc
26 May 2021
 

CIRCASSIA GROUP PLC

Settlement Agreement reached with Beyond Air

 

 

Oxford, UK - 26 May 2021: Circassia Group plc ("Circassia" or "the Company"; AIM: CIR), a medical device company focused on respiratory diagnostics and monitoring, today announces that it has signed an agreement to settle its contractual dispute with Beyond Air Inc. with regard to the licensing to Circassia by Beyond Air in January 2019 of its LungFit® product (the "Settlement").

 

Under the terms of the original licence agreement, Circassia issued $10.5 million of Circassia shares to Beyond Air during the first half of 2019. Under the terms of the Settlement, Circassia will surrender its rights to the LungFit® product in exchange for payments by Beyond Air for up to a maximum of $16.5 million, payable in cash as follows:

 

· $2.5 million within 60 days of the approval of LungFit® by the FDA ("FDA approval")

· $3.5 million within 60 days of the first anniversary of FDA approval

· $4.5 million within 60 days of the second anniversary of FDA approval

 

Circassia will also be entitled to a further royalty of 5% of net sales of LungFit®, commencing on the second anniversary of FDA approval and capped at a maximum of $6 million.

 

 

Ian Johnson, Circassia's Executive Chairman, said: "We are pleased to have been able to resolve this dispute without recourse to formal arbitration, with its associated long timescales and significant legal expense."

 

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR") and is disclosed in accordance with the Company's obligations under UK MAR. This announcement is being made on behalf of the Company by the directors named below.

 

 

 

Contacts

Circassia

Ian Johnson, Executive Chairman Tel: +44 (0) 1865 405 560

Michael Roller, Chief Financial Officer

 

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell/ Jen Boorer/ Hannah Woodley Tel: +44 (0) 20 7496 3000

 

 

 

About Circassia

Circassia is a medical device company focused on respiratory diagnostics and monitoring. Our market-leading NIOX® products are used in clinical settings by physicians around the world to help improve asthma diagnosis and management and by leading research organisations conducting clinical studies on behalf of pharmaceutical companies. Customers are able to buy products and receive customer service via dedicated teams in the United States, UK, Sweden, Germany and China, on-line in some regions and our network of global partners. For more information please visit www.circassia.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFFFSIETIEFIL
Date   Source Headline
31st Dec 20157:00 amRNSTotal Voting Rights
9th Dec 201511:50 amRNSHolding(s) in Company
9th Dec 20157:00 amRNSBoard Changes
30th Nov 20157:00 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSRegulatory Approval
10th Nov 20154:20 pmRNSHolding(s) in Company
30th Oct 20157:00 amRNSTotal Voting Rights
27th Oct 20157:00 amRNSBusiness Update
30th Sep 201511:48 amRNSTotal Voting Rights
18th Sep 20156:18 pmRNSDirector/PDMR Shareholding
9th Sep 20155:55 pmRNSDirector Declaration
28th Aug 20153:34 pmRNSTotal Voting Rights
27th Aug 20155:38 pmRNSDirector Dealing
31st Jul 20159:54 amRNSTotal Voting Rights
30th Jul 20153:45 pmRNSHolding(s) in Company
28th Jul 20157:00 amRNSInterim Results
20th Jul 20153:53 pmRNSNotice of Interim Results
30th Jun 20159:28 amRNSBlock Listing Six Monthly Return
30th Jun 20159:23 amRNSTotal Voting Rights
30th Jun 20157:00 amRNSAerocrine-Increased Acceptances In Offer Period
26th Jun 20154:15 pmRNSHolding(s) in Company
15th Jun 20151:19 pmRNSCompletion of acquisition of Prosonix Limited
15th Jun 20157:00 amRNSAerocrine - extension of offer period
12th Jun 20155:33 pmRNSTR1 Notification of Major Interest in Shares
12th Jun 20153:22 pmRNSNotification Of Major Interest In Shares
11th Jun 20153:00 pmRNSNotification Of Major Interest In Shares
11th Jun 20158:09 amRNSTotal Voting Rights
10th Jun 201511:56 amRNSResult of General Meeting
9th Jun 20157:00 amRNSResults of the placing and open offer
29th May 201511:16 amRNSTotal Voting Rights Update
29th May 201511:11 amRNSDirector Dealing - Correction
20th May 20155:43 pmRNSResult of AGM
18th May 20153:14 pmRNSPublication of Circular and Prospectus
15th May 20156:40 pmRNSDetails of the placing and open offer
15th May 20153:16 pmRNSDetails of the Placing and Open Offer
15th May 20157:04 amRNSIssue of Equity
15th May 20157:00 amRNSAcquisition
8th May 201510:07 amRNSDirector/PDMR Shareholding
6th May 20156:09 pmRNSHolding(s) in Company
1st May 20151:36 pmRNSHolding(s) in Company
30th Apr 20157:00 amRNSTotal Voting Rights
31st Mar 20157:00 amRNSTotal Voting Rights
27th Mar 20154:30 pmRNSAnnual Financial Report
5th Mar 20152:58 pmRNSHolding(s) in Company
5th Mar 20152:53 pmRNSHolding(s) in Company
27th Feb 20157:00 amRNSTotal Voting Rights
26th Feb 20157:01 amRNSFinal Results
9th Feb 201510:00 amRNSAppointment of Lota S Zoth
30th Jan 20151:02 pmRNSTotal Voting Rights
27th Jan 20154:46 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.